These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2088853)

  • 21. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS; Koenig-Berard E; Van Gilst WH
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets.
    Lupi R; Del Guerra S; Bugliani M; Boggi U; Mosca F; Torri S; Del Prato S; Marchetti P
    Eur J Endocrinol; 2006 Feb; 154(2):355-61. PubMed ID: 16452552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
    Sargent CA; Sleph PG; Dzwonczyk S; Smith MA; Normandin D; Antonaccio MJ; Grover GJ
    J Pharmacol Exp Ther; 1993 May; 265(2):609-18. PubMed ID: 8496812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.
    Clapperton M; McMurray J; Fisher AC; Dargie HJ
    Br J Clin Pharmacol; 1994 Jul; 38(1):53-6. PubMed ID: 7946937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolongation by captopril of action potential duration in the normal and hypertrophied rat ventricle: direct action or inhibition of the local angiotensin converting enzyme?
    Ribuot C; Cardinal R; Gouin L; Moreau P; Godin D; Vermeulen M; de Champlain J; Rochette L; Nadeau R
    Cardiovasc Res; 1994 Feb; 28(2):221-7. PubMed ID: 8143304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.
    Inukai T; Yoshida N; Wakabayashi S; Inukai Y; Matsutomo R; Takanashi K; Nakamachi T; Takebayashi K; Aso Y; Takahashi K
    Am J Med Sci; 2005 May; 329(5):222-7. PubMed ID: 15894863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts.
    Anderson B; Khaper N; Dhalla AK; Singal PK
    Can J Cardiol; 1996 Oct; 12(10):1099-104. PubMed ID: 9191504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?].
    Becker BF; Reinholz N; Leipert B; Raschke P; Gerlach E
    Klin Wochenschr; 1991; 69 Suppl 24():6-9. PubMed ID: 1650863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ACE inhibitors with SH groups have no effect of ATP-dependent K channels--a dissertation].
    Köppel H; Gasser R; Klein W; Holzmann S
    Acta Med Austriaca; 1996; 23(3):109-12. PubMed ID: 8967287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
    Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.
    Sacco G; Mario B; Lopez G; Evangelista S; Manzini S; Maggi CA
    Vascul Pharmacol; 2009; 50(5-6):166-70. PubMed ID: 19344651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction.
    Engelman RM; Rousou JA; Iyengar J; Das DK
    Ann Thorac Surg; 1991 Oct; 52(4):918-26. PubMed ID: 1929658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size.
    Lazar HL; Bao Y; Rivers S; Colton T; Bernard SA
    Ann Thorac Surg; 2001 Aug; 72(2):548-53; discussion 553-4. PubMed ID: 11515896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats.
    Krishan P; Sharma A; Singh M
    Pharmacol Res; 1998 Jan; 37(1):23-9. PubMed ID: 9503476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species.
    Cominacini L; Pasini A; Garbin U; Evangelista S; Crea AE; Tagliacozzi D; Nava C; Davoli A; LoCascio V
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):891-5. PubMed ID: 12372676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of captopril and enalaprilat, angiotensin-converting enzyme inhibitors, on para-nonylphenol-induced *OH generation and dopamine efflux in rat striatum.
    Obata T; Takahashi S; Kashiwagi Y; Kubota S
    Toxicology; 2008 Sep; 250(2-3):96-9. PubMed ID: 18611425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function.
    Zhu BQ; Sievers RE; Browne AE; Lee RJ; Chatterjee K; Grossman W; Karliner JS; Parmley WW
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):31-7. PubMed ID: 12692751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ACE inhibitors on oxidation of human low density lipoprotein.
    Godfrey EG; Stewart J; Dargie HJ; Reid JL; Dominiczak M; Hamilton CA; McMurray J
    Br J Clin Pharmacol; 1994 Jan; 37(1):63-6. PubMed ID: 8148219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
    Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
    Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.